Parkinson's disease in the Western Pacific Region
Shen-Yang Lim, Ai Huey Tan, Azlina Ahmad-Annuar, Christine Klein, Louis CS Tan, Raymond L Rosales, Roongroj Bhidayasiri, Yih-Ru Wu, Hui-Fang Shang, Andrew H Evans, Pramod K Pal, Nobutaka Hattori, Chong Tin Tan, Beomseok Jeon, Eng-King Tan, Anthony E Lang
The Lancet Neurology | ELSEVIER SCIENCE INC | Published : 2019
Awarded by University of Malaya Parkinson's Disease and Movement Disorders Research Program Fund
We gratefully acknowledge the following individuals for providing data or insights from their respective countries or territories, or areas of expertise: Mandy Auyeung (Hong Kong), Samleng Chan (Cambodia), Victor SC Fung (Australia), Taku Hatano (Japan), Seong-Beom Koh (Parkinson's disease epidemiology in South Korea), Minh Le (Vietnam), Woong-Woo Lee (Parkinson's disease epidemiology in South Korea), Angus Macleod (Parkinson's disease epidemiology and mortality), Connie Marras (University of Toronto, ON, Canada) (Parkinson's disease epidemiology in North America), Victor McConvey (Australia; Allied health care), Vincent Chung Tong Mok (Hong Kong), Elena Moro (DBS), Weerasak Muangpaisan (Parkinson's disease epidemiology), Emma Nichols (Institute for Health Metrics and Evaluation; Global Burden of Disease), Yasushi Osaki (Parkinson's disease epidemiology in Japan), Eric Roberts (Public Health Institute, CA, USA, and the Parkinson's Foundation P4 group; Parkinson's disease epidemiology), Mark Simpson (New Zealand), Yu Sun (Parkinson's disease epidemiology in Taiwan), Frandy Susatia (Indonesia), Tran Ngoc Tai (Vietnam), Yeremia Tatang (Indonesia), Wesley Thevathasan (DBS in Australia), Bayasgalan Tserensodnom (Mongolia), and Somchit Vorachit (Laos). S-YL and AHT obtained funding from the University of Malaya Parkinson's Disease and Movement Disorders Research Program Fund (PV035-2017) for M G Rudakewich (Synapse Visuals, Edmonton, AB, Canada) to produce figures 1 and 2. E-KT acknowledges support from the National Medical Research Council, Singapore (STaR and Singapore Parkinson's Disease Programme Grant [SPARK 1 & 2]). Funding sources had no involvement in the writing of the manuscript or the decision to submit for publication.